2020
DOI: 10.1111/1471-0528.16504
|View full text |Cite
|
Sign up to set email alerts
|

Role of carbon nanoparticle suspension in sentinel lymph node biopsy for early‐stage cervical cancer: a prospective study

Abstract: Objective To evaluate the clinical diagnostic validity of carbon nanoparticle suspension (CNS) in sentinel lymph node biopsy (SLNB) for assessing lymphatic spread of early‐stage cervical cancer. Design A prospective study. Setting and population 356 cases. Methods We enrolled 356 stage Ia2‐IIa2 cervical cancer patients to undergo SLNB using CNS, followed by systematic pelvic lymphadenectomy. All lymph node specimens were assessed using conventional histopathologic ± pathologic ultrastaging analyses. Main outco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(22 citation statements)
references
References 37 publications
(46 reference statements)
0
21
1
Order By: Relevance
“…The case survey indicates that laparoscopic SLNB mapping with CNSI may be simple and efficient for patients with early-stage cervical cancer. Ya et al further carried out a prospective study of 356 cases to evaluate the clinical diagnostic validity of CNSI in SLNB for assessing the lymphatic spread of early-stage cervical cancer as shown in Figure 4 [ 81 ]. SLNB with CNSI had a sensitivity of 96.65%, a false-negative rate (FNR) of 4.35%, and a negative predictive value (NPV) of 99.29%, which demonstrates that SLNB with CNSI is safe, feasible, and relatively effective for guiding precise surgical treatment of early-stage cervical cancer.…”
Section: Imagingmentioning
confidence: 99%
See 1 more Smart Citation
“…The case survey indicates that laparoscopic SLNB mapping with CNSI may be simple and efficient for patients with early-stage cervical cancer. Ya et al further carried out a prospective study of 356 cases to evaluate the clinical diagnostic validity of CNSI in SLNB for assessing the lymphatic spread of early-stage cervical cancer as shown in Figure 4 [ 81 ]. SLNB with CNSI had a sensitivity of 96.65%, a false-negative rate (FNR) of 4.35%, and a negative predictive value (NPV) of 99.29%, which demonstrates that SLNB with CNSI is safe, feasible, and relatively effective for guiding precise surgical treatment of early-stage cervical cancer.…”
Section: Imagingmentioning
confidence: 99%
“… The technique of CNSI application in SLNB for assessing lymphatic spread of early-stage cervical cancer [ 81 ]. ( A ) Injecting CNSI into the ectocervix at the 3 and 9 o’clock positions superficially by a skin test needle, approximately 5–10 mm from the tumor border and perpendicular to the cervix surface.…”
Section: Figurementioning
confidence: 99%
“…The mean size of the CNS is 150 nm, allowing it to easily travel through the lymphatic capillary with an average epithelial gap of 120 to 500 nm but not the blood capillary with an average epithelial gap of 20 to 50 nm. Because of this, CNS has been widely used in diverse fields of surgery [ 12 , 13 ]. During the surgical resection of a tumor, CNS particles migrate quickly in lymphatic vessels and accumulate in lymph nodes, staining them black.…”
Section: Discussionmentioning
confidence: 99%
“…A study of 356 patients with stage IA2-IIA2 cervical cancer underwent systematic pelvic lymphadenectomy after SLN biopsy with carbon nanoparticles suspension ( 56 ). Results showed that the overall sensitivity was 96.65%, the false-negative rate was 4.35%, and the negative predictive value was 99.29% ( 56 ). The sensitivity and negative predictive value were both 100% and the false-negative rate was reduced to 0% for tumors <2 cm ( 56 ).…”
Section: Introduction To Sentinel Lymph Node Techniquesmentioning
confidence: 99%